What is a Major Criticism of Managed Care Programs?

Managed care programs have become a cornerstone of the healthcare system in the United States since the 1970s, aiming to control costs and improve efficiency. These programs, encompassing Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs), and Point of Service (POS) plans, operate under the principle of managing healthcare delivery through various strategies, including provider networks, utilization reviews, and financial incentives. While managed care has been credited with certain improvements in healthcare delivery, it faces significant criticisms, primarily centered around restrictions on patient choice and potential compromises in the quality of care due to cost-containment measures.

One of the most frequently cited criticisms of managed care programs revolves around the limitation of patient choice and access to healthcare providers. Managed care organizations often establish networks of providers, and plans like HMOs typically require patients to choose a primary care physician within the network for referrals to specialists. This network restriction can limit patients’ options, forcing them to switch doctors they trust or travel further to see an in-network provider. While PPOs offer more flexibility by allowing out-of-network care, it comes at a higher cost to the patient. This network-centric approach can disrupt established patient-physician relationships and create barriers to accessing specialists, particularly for patients with complex or chronic conditions who may benefit from seeing specific out-of-network experts.

Furthermore, a significant concern is that the emphasis on cost containment in managed care may prioritize financial considerations over the quality of patient care. Managed care organizations employ utilization management techniques, such as pre-authorization for procedures and medications, to control expenses. While intended to prevent unnecessary care, these processes can lead to delays in treatment and denials of necessary services. Medication formularies, which are lists of preferred drugs, are another cost-saving tool that can restrict physicians’ prescribing options, potentially forcing patients onto less effective or unsuitable medications simply because they are on the formulary and therefore cheaper.

The financial incentives embedded within some managed care models, like capitation (where providers are paid a fixed amount per patient regardless of the services provided), also raise concerns about potential under-treatment. To maximize profits under capitation, there’s a risk that providers might limit necessary services or referrals to specialists, potentially compromising patient outcomes. While proponents argue these incentives encourage preventative care and efficiency, critics worry about the ethical implications of financially incentivizing reduced care.

Beyond patient access and quality of care, other criticisms include the administrative burden imposed by managed care. Navigating pre-authorizations, referrals, and network rules can be complex and time-consuming for both patients and providers, adding to administrative costs and frustrations. The lack of transparency in how managed care organizations make decisions about coverage and care is another point of contention, making it difficult for patients to understand why certain treatments are approved or denied.

It’s important to acknowledge that managed care has also brought benefits to the healthcare system. It has encouraged preventative care, streamlined certain processes, and in some cases, improved outcomes through coordinated care approaches. However, the criticisms regarding patient choice and the potential for cost-driven compromises in care quality remain major concerns. The ongoing debate surrounding managed care reflects the inherent tension between controlling healthcare costs and ensuring patients receive the best possible care tailored to their individual needs.

References

1. Perez V. Effect of privatized managed care on public insurance spending and generosity: Evidence from Medicaid. Health Econ. 2018 Mar;27(3):557-575. [PubMed: 29168257]
2. Romano PM. Managed care accreditation: the process and early findings. J Healthc Qual. 1993 Nov-Dec;15(6):12-6; quiz 16. [PubMed: 10129527]
3. Dorsey JL. The Health Maintenance Organization Act of 1973 (P.L. 93-222) and prepaid group practice plans. Med Care. 1975 Jan;13(1):1-9. [PubMed: 803289]
4. Harrison DH, Kimberly JR. Private and public initiatives in health maintenance organizations. J Health Polit Policy Law. 1982 Spring;7(1):80-95. [PubMed: 7108171]
5. Iglehart JK. Future of Long-Term Care and the Expanding Role of Medicaid Managed Care. N Engl J Med. 2016 Jan 14;374(2):182-7. [PubMed: 26760091]
6. Butler SM. How an Expanded Vision of Managed Care Organizations Could Tackle Inequities. JAMA. 2019 Jun 04;321(21):2063-2064. [PubMed: 31162558]
7. Ndumele CD, Schpero WL, Trivedi AN. Medicaid Expansion and Health Plan Quality in Medicaid Managed Care. Health Serv Res. 2018 Aug;53 Suppl 1(Suppl Suppl 1):2821-2838. [PMC free article: PMC6056574] [PubMed: 29230801]
8. Healy-Collier K, Jones WJ, Shmerling JE, Robertson KR, Ferry RJ. Medicaid managed care reduces readmissions for youths with type 1 diabetes. Am J Manag Care. 2016 Apr;22(4):250-6. [PubMed: 27143290]
9. Kelleher KJ, Cooper J, Deans K, Carr P, Brilli RJ, Allen S, Gardner W. Cost saving and quality of care in a pediatric accountable care organization. Pediatrics. 2015 Mar;135(3):e582-9. [PubMed: 25667248]
10. Komives E. Is the Move to Value-Based Care More Than Managed Care Redux? N C Med J. 2016 Jul-Aug;77(4):283-5. [PubMed: 27422955]
11. Nadash P, Ahrens J. Managed care and long-term care: a potential solution? Policy Brief (Cent Home Care Policy Res). 2005 Winter;(20):1-6. [PubMed: 15795990]
12. Schauffler HH, Scutchfield FD. Managed care and public health. Am J Prev Med. 1998 Apr;14(3):240-1. [PubMed: 9569227]
13. Grammer D. How to Succeed Under Medicaid Managed Care. N C Med J. 2019 Sep-Oct;80(5):312-316. [PubMed: 31471518]
14. Dalzell MD. Truce! Like it or not, managed care is here to stay. Trust is still thin, but physicians and plans are learning to collaborate. Manag Care. 1998 Aug;7(8):17-21. [PubMed: 10182579]
15. Wallack SS. Managed care: practice, pitfalls, and potential. Health Care Financ Rev Annu Suppl. 1991:27-34. [PubMed: 10117117]